Rachid Ouzérourou

Title: Rachid Ouzérourou: Innovator in Sustained-Release Formulations

Introduction

Rachid Ouzérourou is a notable inventor based in Montreal, Canada. He has made significant contributions to the field of pharmaceutical formulations, particularly in pain management. His innovative work has led to the development of a unique sustained-release tramadol formulation.

Latest Patents

Ouzérourou holds a patent for "Sustained-release tramadol formulations with 24-hour efficacy." This formulation allows for oral administration that provides an analgesic effect within two hours of the initial dose. Remarkably, this analgesic effect continues for at least 24 hours after administration, offering a significant advancement in pain relief.

Career Highlights

Throughout his career, Rachid Ouzérourou has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with Labopharm Inc. and Labopharm Europe Limited. His work in these organizations has contributed to the development of innovative drug delivery systems.

Collaborations

Ouzérourou has collaborated with several professionals in his field, including Vincent Lenaerts and Patricia Laure Ouadji-Nijki. These collaborations have fostered a creative environment that has led to advancements in pharmaceutical formulations.

Conclusion

Rachid Ouzérourou's contributions to sustained-release formulations exemplify his commitment to improving pain management solutions. His innovative patent and collaborations highlight his role as a significant figure in the pharmaceutical industry.